DANIEL CHANG: Open Payments
NPI 1962728022 · YORBA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 60 payments from 14 companies in 2025. Trend: 2023 $935 · 2024 $1,014 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $437 |
| Janssen Biotech, Inc. | 9 | $186 |
| Galderma Laboratories, L.P. | 14 | $173 |
| Incyte Corporation | 3 | $81 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $72 |
| UCB, Inc. | 2 | $51 |
| GENZYME CORPORATION | 1 | $50 |
| Verrica Pharmaceuticals Inc. | 2 | $48 |
| Krystal Biotech Inc | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: RINVOQ, TREMFYA, NEMLUVIO, SKYRIZI, OPZELURA, Winlevi, Bimzelx, DUPIXENT.
Industry payments across CA — which companies pay providers there.
